XML 38 R8.htm IDEA: XBRL DOCUMENT v3.3.0.814
Consolidated Statements Of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Statement Of Cash Flows [Abstract]    
Net income $ 1,048 $ 170
Adjustments to reconcile net loss to net cash from operating activities:    
Provision for loan losses 200 203
Depreciation 157 179
Amortization, net 36 169
Net loss on sales of securities 12  
Originations of loans held for sale (40,032) (40,280)
Proceeds from sale of loans held for sale 44,054 38,061
Net gains on sales of loans (357) (356)
Earnings on bank owned life insurance (98) (97)
Stock-based compensation expense 102 218
Net change in:    
Accrued interest receivable and other assets 665 350
Accrued interest payable and other liabilities (171) (52)
Net cash from (used in) operating activities 5,616 (1,435)
Cash flows from investing activities    
Net (increase) decrease in interest-bearing deposits in other financial institutions   1,240
Available-for-sale securities:    
Maturities, prepayments and calls 3,403 1,398
Purchases (4,573)  
Loan originations and payments, net (31,440) (41,274)
Proceeds from the sale of loans 4,099  
Additions to premises and equipment (38) (456)
Net cash used by investing activities (28,549) (39,092)
Cash flows from financing activities    
Net change in deposits 15,479 42,630
Net change in short-term borrowings from the FHLB and other debt   (6,526)
Proceeds from long-term FHLB advances and other debt 2,500 12,000
Repayments on long-term FHLB advances and other debt (2,500) (7,500)
Net change in advances by borrowers for taxes and insurance (90) (363)
Cash dividends paid on Series B preferred stock (562) (59)
Net proceeds from issuance of Series B preferred stock   11,369
Net cash from financing activities 14,827 51,551
Net change in cash and cash equivalents (8,106) 11,024
Beginning cash and cash equivalents 28,207 19,160
Ending cash and cash equivalents 20,101 30,184
Supplemental cash flow information:    
Interest paid 1,926 1,084
Supplemental noncash disclosures:    
Loans transferred from held for sale to portfolio 834  
Loans transferred from portfolio to held for sale 1,561  
Dividends payable on Series B preferred stock $ 187 $ 174